Clinical Cancer Research · 2004 · 254 citations · 46 references
MedicineOncologyPathologyCarcinogenesisGastrointestinal OncologyMetastasisCancer BiomarkersCancer Molecular PathologyColorectal CancerLiver MetastasisMalignant NeoplasmsClinicopathologic FeaturesColorectal Cancer BiomarkersColorectal Cancer PathologyColorectal Cancer PrognosisLymph Node MetastasesLymph Node Metastasis PrognosisPrognostic BiomarkersTumor Size Prognosis
PURPOSE: Recent studies have shown that cyclooxygenase (Cox)-2 may be involved in colorectal carcinogenesis. We aimed to determine whether Cox-2 expression in itself can predict outcome of colorectal cancer patient after surgery. In addition, the expression of Cox-1 was also evaluated. EXPERIMENTAL DESIGN: Tissue samples of primary and secondary tumors from 288 patients undergoing surgical resections for colorectal adenocarcinoma were immunohistochemically examined for Cox-2 and Cox-1 expressions. The specimens were graded based on the intensity and extent of staining; then, the correlations between Cox-2 and Cox-1 expressions with clinicopathologic parameters and survival time were analyzed. RESULTS: Expression of Cox-2 was positive in 70.8% of primary tumor, 92.0% of lymph node metastases, 100.0% of hepatic metastases, and was significantly associated with tumor size, depth of invasion, lymph node metastasis, vessels invasion, stage and recurrence. In contrast, Cox-1 was positive in 42.7% of primary tumor, 84.0% of lymph node metastases, 37.5% hepatic metastases, and was associated with only tumor size. Patients with Cox-2-positive tumors had a significant shorter survival time than those with negative tumors did (P = 0.0006 by log-rank test); and, in a multivariate analysis, Cox-2 was an independent prognostic factor (P = 0.0103; relative risk 4.114; 95% confidence interval, 1.397-12.120). Cox-1 status had no statistically effect on patient survival time. CONCLUSIONS: Elevated Cox-2 expression, but not that of Cox-1, was significantly associated with reduced survival and recognized as an independent prognostic factor in our cohort of colorectal cancer patients.
46
Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells
Masahiko Tsujii, Sunao Kawano, Shingo Tsuji et al. · Cell · 1998 · 2.3K citations · Full text
Medicine, Cancer Biology, Oncology +14
Aspirin Use and Reduced Risk of Fatal Colon Cancer
Michael J. Thun, Mohan M. Namboodiri, Clark W. Heath · New England Journal of Medicine · 1991 · 1.7K citations · Full text
Medicine, Oncology, Pharmacology +12